Individualised benefit–harm balance of aspirin as primary prevention measure – a good proof-of-concept, but could have been better…
Crossref DOI link: https://doi.org/10.1186/s12916-016-0648-9
Published Online: 2016-07-06
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Thorat, Mangesh A.
License valid from 2016-07-06